Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
S2Medical ABFRA:S21 Gross Margin % is 101.46% as of Dec. 2025, which is 3% below its 10-year median of 104.20. The stock has 3 warning signs investors should review. Among 805 Medical Devices & Instruments companies, S2Medical AB ranks better than 98.76% on this metric.
The historical rank and industry rank for S2Medical AB's Gross Margin % or its related term are showing as below:
FRA:S21'
s Gross Margin % Range Over the Past 10 Years
Min: 39.23 Med: 104.2 Max: 758.24
Current: 101.38
During the past 10 years, the highestGross Margin % of S2Medical AB was 758.24%. The lowest was 39.23%. And the median was 104.20%.
FRA:S21's Gross Margin % is ranked better than 98.76% of 805
companies
in the Medical Devices & Instruments industry
Industry Median: 52.07
vs FRA:S21: 101.38
S2Medical AB had a gross margin of 101.46% for the quarter that ended in Dec. 2025 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for S2Medical AB was 12.80% per year.
S2Medical AB (FRA:S21) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
S2Medical AB had a gross margin of 101.46% for the quarter that ended in Dec. 2025 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
S2Medical AB Gross Margin % Related Terms
S2Medical AB Gross Margin % Historical Data
* Premium members only.
The historical data trend for S2Medical AB's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:S21 vs ISRG, BDX, MDLN: Gross Margin % Comparison
For the Medical Instruments & Supplies subindustry, S2Medical AB's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
S2Medical AB Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, S2Medical AB's Gross Margin % distribution charts can be found below:
* The bar in red indicates where S2Medical AB's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
S2Medical AB (FRA:S21) has a Gross Margin % of 101.46% as of Dec. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on S2Medical AB and its competitors. This is near median its historical median of 104.20. Over the past decade, S2Medical AB's Gross Margin % has ranged from 39.23 to 758.24. According to the industry distribution chart, S2Medical AB ranks #10 out of 805 companies in the Medical Devices & Instruments industry, placing it in the top 1.2%.
Is S2Medical AB's Gross Margin % too high?
S2Medical AB's current Gross Margin % of 101.46% is near median its 10-year median of 104.20. Over the past 10 years, this metric has ranged from a low of 39.23 to a high of 758.24. The Medical Devices & Instruments industry median Gross Margin % is 52.07. S2Medical AB's value of 101.46% is 94.9% above this industry median. Based on the distribution chart, S2Medical AB ranks #10 out of 805 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers.
How does S2Medical AB's Gross Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, S2Medical AB ranks #10 out of 805 companies for Gross Margin %. This places S2Medical AB in the top 1% of its industry — outperforming the majority of peers. The industry median Gross Margin % is 52.07. S2Medical AB's value of 101.46% is 94.9% above this benchmark. Historically, S2Medical AB's own Gross Margin % has ranged from 39.23 to 758.24 over the past decade. While the company's 10-year median is 104.20 vs. the industry median of 52.07, S2Medical AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 52.07, based on 805 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. S2Medical AB's current Gross Margin % of 101.46% is 94.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on S2Medical AB and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 52.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. S2Medical AB's current Gross Margin % is 101.46%, which is near median its own 10-year median of 104.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is S2Medical AB stock overvalued right now?
S2Medical AB (FRA:S21) has a current Gross Margin % of 101.46%. The current Gross Margin % is 101.46%, which is near median its 10-year median of 104.20 and 94.9% above the Medical Devices & Instruments industry median of 52.07. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For S2Medical AB (FRA:S21), the current Gross Margin % is 101.46% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
S2Medical AB is a research-intensive MedTech company from Sweden. The company develops products within the entire wound healing process from debridement and granulation to re-epithelialization. products for the initial phase of a wound's healing process until the end, when the wound is completely healed. S2Medical also has in its portfolio the product NoSmell for odor removal which is procured in several different Swedish healthcare regions.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:S21 has been successfully added to your 
